Lam Research (NASDAQ: LRCX) insider transactions
In the twelve months to 10 November 2026, executives and directors of Lam Research reported 67 open-market sales of 689,829 shares ($175.8m) and 0 open-market purchases, by 8 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 6 November 2026 | Mayer Bethany | Director | Grant or award, 10b5-1 plan | +856 | — | 1,772 | Form 4 |
| 6 November 2026 | Mayer Bethany | Director | Open-market sale, 10b5-1 plan | −16 | $208.50 | 1,756 | Form 4 |
| 6 November 2026 | Brandt Eric | Director | Grant or award | +856 | — | 145,561 | Form 4 |
| 6 November 2026 | Fields Mark | Director | Grant or award | +856 | — | 6,178 | Form 4 |
| 6 November 2026 | Talwalkar Abhijit Y | Director | Grant or award | +856 | — | 87,998 | Form 4 |
| 6 November 2026 | Brennan Ita M | Director | Grant or award | +856 | — | 6,198 | Form 4 |
| 6 November 2026 | Devgan Anirudh | Director | Grant or award | +856 | — | 1,997 | Form 4 |
| 6 November 2026 | Dineen John M. | Director | Grant or award | +856 | — | 9,991 | Form 4 |
| 6 November 2026 | Mehra Jyoti | Director | Grant or award | +856 | — | 19,331 | Form 4 |
| 6 November 2026 | Kang Ho Kyu | Director | Grant or award | +856 | — | 10,029 | Form 4 |
| 2 November 2026 | Mayer Bethany | Director | Open-market sale, 10b5-1 plan | −719 | $242.59 | 916 | Form 4 |
| 30 October 2026 | Kang Ho Kyu | Director | Shares withheld for tax | −491 | $239.11 | 9,173 | Form 4 |
| 23 October 2026 | Archer Timothy | President and CEO | Option exercise, 10b5-1 plan | +31,400 | $30.03 | 1,107,366 | Form 4 |
| 23 October 2026 | Archer Timothy | President and CEO | Open-market sale, 10b5-1 plan | −31,400 | $227.02 | 1,075,966 | Form 4 |
| 9 September 2026 | Archer Timothy | President and CEO | Option exercise, 10b5-1 plan | +30,000 | $30.03 | 1,105,966 | Form 4 |
| 9 September 2026 | Archer Timothy | President and CEO | Open-market sale, 10b5-1 plan | −30,000 | $319.26 | 1,075,966 | Form 4 |
| 9 September 2026 | Mayer Bethany | Director | Open-market sale | −9,557 | $314.74 | 20,995 | Form 4 |
| 2 September 2026 | Varadarajan Seshasayee | Senior Vice President | Open-market sale, 10b5-1 plan | −20,000 | $291.32 | 205,546 | Form 4 |
| 2 September 2026 | Varadarajan Seshasayee | Senior Vice President | Option exercise, 10b5-1 plan | +12,270 | $59.88 | 217,816 | Form 4 |
| 2 September 2026 | Varadarajan Seshasayee | Senior Vice President | Open-market sale, 10b5-1 plan | −12,270 | $291.32 | 205,546 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Lam Research page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.